ATE123072T1 - Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper. - Google Patents

Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.

Info

Publication number
ATE123072T1
ATE123072T1 AT89906299T AT89906299T ATE123072T1 AT E123072 T1 ATE123072 T1 AT E123072T1 AT 89906299 T AT89906299 T AT 89906299T AT 89906299 T AT89906299 T AT 89906299T AT E123072 T1 ATE123072 T1 AT E123072T1
Authority
AT
Austria
Prior art keywords
antibodies
human immune
test system
producing non
detecting
Prior art date
Application number
AT89906299T
Other languages
English (en)
Inventor
Kurt A Osther
Original Assignee
Verigen Inc A Corp Of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verigen Inc A Corp Of Delaware filed Critical Verigen Inc A Corp Of Delaware
Application granted granted Critical
Publication of ATE123072T1 publication Critical patent/ATE123072T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT89906299T 1988-05-10 1989-05-10 Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper. ATE123072T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/192,241 US5008183A (en) 1988-05-10 1988-05-10 Assay system for detecting antibody and a method of producing non-human immune antibody

Publications (1)

Publication Number Publication Date
ATE123072T1 true ATE123072T1 (de) 1995-06-15

Family

ID=22708839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906299T ATE123072T1 (de) 1988-05-10 1989-05-10 Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.

Country Status (7)

Country Link
US (1) US5008183A (de)
EP (1) EP0383851B1 (de)
AT (1) ATE123072T1 (de)
AU (1) AU3689389A (de)
CA (1) CA1338412C (de)
DE (1) DE68922842T2 (de)
WO (1) WO1989010980A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264342A (en) * 1988-05-10 1993-11-23 Verigen, Inc. Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
EP0429218A1 (de) * 1989-11-17 1991-05-29 Baxter Diagnostics Inc. Antikörper von nichtmenschlichen Primaten zum Gebrauch als positive Kontrolle für Immunglobulinbestimmungen
US7585512B1 (en) * 1990-05-08 2009-09-08 Thomas Jefferson University Composition and method of using tumor cells
JPH06502723A (ja) * 1990-11-09 1994-03-24 ヴェリジェン，インコーポレーテッド 抗体を検出する分析系の感度及び／又は特異性の決定方法
WO1992018865A1 (en) * 1991-04-11 1992-10-29 Cedars-Sinai Medical Center Immunoassay for the detection of hiv specific igm
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
US6319665B1 (en) 1994-06-07 2001-11-20 Inverness Medical Technology, Inc. Home test kit and method with telephone verification of results
US6015662A (en) * 1996-01-23 2000-01-18 Abbott Laboratories Reagents for use as calibrators and controls
US6673614B2 (en) 2000-06-27 2004-01-06 Cell Genesys, Inc. Rapid methods and kits for detection and semi-quantitation of anti-adenovirus antibody
US20100009389A1 (en) * 2008-07-14 2010-01-14 Masood Unnabi Khan Method of Making and Using Versatile Positive Controls and Antibody Detection Assays
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4474877A (en) * 1980-09-19 1984-10-02 Research And Education Institute, Inc. Harbor - Ucla Medical Center Process for detection and measurement of viral specific immunoglobulins and article of manufacture therefor
CA1240937A (en) * 1982-07-26 1988-08-23 Gordon R. Dreesman Monoclonal igm antibodies and method of preparation
JPH0651643B2 (ja) * 1983-01-19 1994-07-06 帝人株式会社 殺細胞性修飾免疫グロブリン及びその製造方法
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
US4774175A (en) * 1985-03-01 1988-09-27 Centocor, Inc. Immunochemical methods for the detection of antibody against HTLV-III
US4661445A (en) * 1985-05-24 1987-04-28 Saxinger W Carl Competitive ELISA for the detection of HTLV-III antibodies
DK151087A (da) * 1987-03-25 1988-09-26 Kurt Baekgaard Osther Method for detection of hiv (htlv iii/lav) viral antigens in cells, serum and other bodyfluids

Also Published As

Publication number Publication date
EP0383851A4 (en) 1992-05-20
DE68922842D1 (de) 1995-06-29
DE68922842T2 (de) 1995-09-21
EP0383851B1 (de) 1995-05-24
US5008183A (en) 1991-04-16
EP0383851A1 (de) 1990-08-29
CA1338412C (en) 1996-06-18
AU3689389A (en) 1989-11-29
WO1989010980A1 (en) 1989-11-16

Similar Documents

Publication Publication Date Title
DE68922842D1 (de) Testsystem zum nachweis von antikörpern und methode zur herstellung nichtmenschlicher immunantikörper.
EP0351248A3 (en) Detection of an antibody and antigen in an immunoassay
GR940300008T1 (de)
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
NZ230148A (en) Ibd (infectious bursal disease) monoclonal antibody vaccines, immunised chicks and a method of assaying for ibd
CU22615A1 (es) Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
ES548270A0 (es) Un metodo de inmunoensayo
ES2082775T4 (es) Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE68925899D1 (de) Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen
DE3584035D1 (de) Nachweis von menschlichem cytomegalovirus-spezifischem igm.
ATE2699T1 (de) Serologisches verfahren zum nachweis von neisseria gonorrhoeae antikoerpern im menschlichen serum, ein dazu angewendetes speziesspezifisches waermestabiles antigen und verfahren zur herstellung dieses antigens.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
NO174153C (no) Antigen og monoklonalt antistoff for anvendelse in vitro, samt immunologiske reagenser inneholdende disse
DE3686717D1 (de) Immuntestverfahren.
JPS6488369A (en) Method of detecting and verifying presence of antibody
ATE132267T1 (de) Immuntest unter verwendung von antigenen, produziert in heterologen organismen
EP0293184A3 (de) Immunodiagnostische Probe mit chimerischen Antigenen
GB2233091A (en) Immunoassays using monoclonal antibodies directed against natural binding proteins
DK608789D0 (da) Cea-immunanalyse uden falske positive foraarsaget af humant anti-museantistof
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
ES2018909A6 (es) Un metodo para producir un polipeptido util en un metodo y sistema de diagnostico para el ensayo de la presencia de anticuerpos anti-ebna enuna muestra corporal.